EcoDrugPlus

Glycogen Synthase Kinase-3 Alpha-Like

Ensembl ID : ENSNBRG00000020141
Gene Symbol: LOC102792707
3 Cross references
186 Possible Orthologues:

Glycogen Synthase Kinase-3 Beta-Like

Ensembl ID : ENSNBRG00000007145
Gene Symbol: LOC102788905
3 Cross references
222 Possible Orthologues:

Granzyme B(G,h)-Like

Ensembl ID : ENSNBRG00000023418
Gene Symbol: LOC102778916
2 Cross references
949 Possible Orthologues:

Granzyme G-Like

Ensembl ID : ENSNBRG00000008228
Gene Symbol: LOC102783686
2 Cross references
951 Possible Orthologues:

Granzyme G-Like

Ensembl ID : ENSNBRG00000023405
Gene Symbol: LOC102778638
2 Cross references
921 Possible Orthologues:

Group 10 Secretory Phospholipase A2-Like

Ensembl ID : ENSNBRG00000015625
Gene Symbol: LOC102793376
3 Cross references
232 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSNBRG00000003269
Gene Symbol: GHRHR
4 Cross references
191 Possible Orthologues:

Growth Hormone Secretagogue Receptor Type 1-Like

Ensembl ID : ENSNBRG00000001815
Gene Symbol: LOC102789973
3 Cross references
212 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSNBRG00000014177
Gene Symbol: GUCY1A2
4 Cross references
202 Possible Orthologues:

Guanylate Cyclase Soluble Subunit Alpha-3-Like

Ensembl ID : ENSNBRG00000013621
Gene Symbol: LOC102782807
3 Cross references
201 Possible Orthologues:

Guanylate Cyclase Soluble Subunit Beta-1-Like

Ensembl ID : ENSNBRG00000013648
Gene Symbol: LOC102783286
3 Cross references
210 Possible Orthologues:

Heat Shock Protein Hsp 90-Alpha 1-Like

Ensembl ID : ENSNBRG00000021887
Gene Symbol: LOC102799602
3 Cross references
330 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).